We are a specialty CNS CRO that supports all phases of development for novel drugs. We provide scientific leadership and have extensive experience with the CNS approval process.
We are a specialty CNS CRO that supports all phases of development for novel drugs. We provide scientific leadership and have extensive experience with the CNS approval process.
We are a specialty CNS CRO that supports all phases of development for novel drugs. We provide scientific leadership and have extensive experience with the CNS approval process.
Our Scientific Leadership Team reviews every new protocol at the bid stage to assess the potential study risks, and works directly with the Sponsor as well as the CRO Project Teams to mitigate them in advance of FPI and then continues to be available throughout the life of the trial. Every Lotus Study is assigned a Scientific Leadership Team member from this list of Clinicians, Research Experts, and Scientists.
Lotus is a science-driven, full-service CRO with a number of unique qualities that no other CRO can provide. One particular differentiator is that we are under common ownership with Evolution Research Group (ERG), which is a clinical site organization with 20+ wholly-owned clinical research sites around the US.
Because of this connection to ERG, Lotus’ Sponsors benefit from one-stop shopping for:
Lotus Clinical Research is proud to be featured in an exciting study in collaboration with Evolution Research Group and Gonzaba Medical Group, exploring the cognitive
We are thrilled to share that our own Lance Ballester presented a poster at the Joint Statistical Meetings Annual Conference in Portland, Oregon this past
Lotus collaborated with ERG and Concentric in vocacapsaicin bunionectomy trial The Lotus Team is thrilled to have collaborated with both ERG and Concentric on this
© 2023 Lotus Clinical Research, LLC. All Rights Reserved
